Blood clots are a dangerous thing that needs to be taken seriously. Blood clots can be a symptom to many different diseases including cardiovascular ones, diabetes or even blood fluidity problems. Clots can lead to strokes or heart attacks, which can have complications as amputation or even lead to death. This is why it is important to have different treatments to help lower the risks of blood clots forming in the body.
A recent study conducted by a team of researchers from Michigan Medicine was focused on people who are affected with antiphospholipid syndrome (APS). In this disease, the blood of the patient gets thick which might lead to blood clots much easier. This is why the main treatment is to intake blood thinners.
The study was led by Ph.D. holder Jason Knight who is an assistant professor of rheumatology at Michigan Medicine. The study was published in the journal of Nature Communications. Dr. Jason commented on his results saying, “Unfortunately, treatment with blood thinners does not prevent all cases of blood clotting in APS. And those blood thinners do very little to impact the neurologic, hematologic and cardiac complications that regularly affect patients with the condition. Specifically, we have been interested in the role that neutrophils, the most abundant white blood cells in circulation within the body, play in APS. We’ve had prior studies demonstrate that neutrophils release sticky, spider web-like structures called neutrophil extracellular traps, also called NETs, that trigger the blood to clot in patients with APS.”